C01 – Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome: Patient Exit Interviews

Published in 2015 Listed under Clinical

Anthony; Hörsch; Ervin; Kulke; Pavel; Bergsland; Caplin; Oberg; Warner; Kunz; Metz; Pasieka; Pavlakis; DiBenedetti; Haydysch; Yang; Jackson; Arnold; Law; Lapuerta

C01 – Laboratory Diagnosis of Gastrinoma Remains Difficult

Published in 2012 Listed under Clinical, Poster

Joy Ardill; Lee Armstrong; Brian Johnston; David McCance

  pdf Download Poster (81 KB)

C01 – Presence of Extra-Hepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Carcinoid

Published in 2010 Listed under Clinical, Poster

Arrese David, Feria-Arias Enrique, Hatzaras Ioannis, Guy Gregory, Khabiri Hooman, Schmidt Carl, Shah Manisha, Bloomston Mark

  pdf Download Poster (3.54 MB)

C01 – Evaluation of the Efficacy and Safety of Lanreotide on Tumor Growth Stabilization in Patients with Progressive NETs Who Are Not Eligible for Treatment with Surgery or Chemotherapy

Published in 2011 Listed under Clinical, Poster

Vicente Alonso, Maribel Marmol, Daniel Castellano, Emilio Fonseca, Amalia Velasco, José Luis García López, Eva Pineda, Pascal Maisonobe, Bertomeu Massutí, Marta Martín-Richard, on behalf of the TTD Study Group

  pdf Download Poster (213 KB)

C02 – Biomarkers in Late Stage Neuroendocrine Tumors of the Small Bowel

Published in 2015 Listed under Clinical

Ardill; Stronge; McDance; Johnston

C02 – Short Term Response to Systemic I-131 MIBG Therapy in Metastatic Carcinoid Tumors.

Published in 2010 Listed under Clinical

Richard J Campeau MD, Lowell B Anthony MD, Eugene A Woltering MD, Yi-Zarn Wang MD, and J Phillip Boudreaux MD

C03 – Gluteal Intramuscular Injections: Techniques Associated with Successful Octreotide LAR Injection

Published in 2009 Listed under Clinical, Poster

April E. Boyd, Colleen C. Leary, James P. Brook, Valentine G. Boving, Cecile G. Dagohoy, Linda L. DeFord, Jeana L. Garris, Jeannette E. Mares, Alexandria T. Phan, James C. Yao

  pdf Download Poster (122 KB)

C03 – Prognostic Criteria Development for Metastatic Well- or moderately-differentiated Neuroendocrine Tumors

Published in 2010 Listed under Clinical, Poster

Lisa M. Caronia, David Arrese, Lai Wei, Carl R. Schmidt, Daria Arbogast, Mark P. Bloomston, Manisha H. Shah

  pdf Download Poster (366 KB)

C03 – A Phase II Study to Evaluate the Safety and Efficacy of RAD001 plus Erlotinib in Patients with Well-Differentiated Neuroendocrine Tumors (NET)

Published in 2011 Listed under Clinical

Emily Bergsland, Lindsey Watt, Andrew Ko, Margaret Tempero, W. Michael Korn, Robin K. Kelley, Tom Weber, Iche Siah, Jimmy Hwang, Eric Nakakura, Alan Venook

C04 – Complete Response to Combination Therapy with 177- Lutetium PRRT and Capecitabine in the Treatment of Thymic Squamous Cell Carcinoma

Published in 2015 Listed under Clinical

Armaghany; Vahdati; Broline; Hamiditabar; Goshen; Rogosnitzky; Giannikopoulos; Caulin; Polkinghorn; Delpassand

C04 – LX1032: A Novel Agent to Reduce Serotonin In Carcinoid Syndrome

Published in 2009 Listed under Clinical, Poster

Philip Brown, Kenny Frazier, Shanna Jackson, Anne Turnage, Qingyun Liu

  pdf Download Poster (730 KB)

C04 – Phase I Study of Pasireotide (SOM230) in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Jennifer A. Chan, MD, MPH,; David P. Ryan, MD; Charles S. Fuchs, MD, MPH,; Andrew X. Zhu, MD, PhD; Thomas A. Abrams, MD, Brian M. Wolpin, MD, MPH,; Carolyn Casey, BS; Eileen Regan, RN, BSN, OCN; Kristen Cavanaugh, RN; Matthew H. Kulke, MD, MMSc

  pdf Download Poster (112 KB)

C04 – The CLARINET Study -- Assessing the Effect of Lanreotide Autogel on Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Published in 2011 Listed under Clinical

Blumberg Joelle, Liyanage Nilani, Caplin Martyn, on behalf of UK & Ireland Neuroendocrine Tumour Society/European Neuroendocrine Tumor Society

C05 – An Expert Panel Consensus on Medical Treatement of Non-Midgut Unresectable Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

Al B. Benson; Jonathan R. Strosberg; George A. Fisher; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples ; Philip. A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

  pdf Download Poster (291 KB)

C05 – Phase I Study of Sorafenib in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Jennifer A. Chan, MD, MPH,; Robert J. Mayer, MD,; Nadine Jackson, MD, MPH,; Paige Malinowski, BA; Eileen Regan, RN, BSN, OCN; Matthew H. Kulke, MD, MMSc

  pdf Download Poster (105 KB)

C05 – Surgical Management of Neuroendocrine Tumors Metastatic to the Liver

Published in 2009 Listed under Clinical

Scott Celinski MD, Jennifer Steel PhD, Kevin Tri Nguyen MD PhD, J. Wallis Marsh MD, David A. Geller MD, Richard Raizman MD, Allan Tsung MD, T. Clark Gamblin MD, MS

C05 – Improved Tumor Dosimetry by Combining 131I-MIBG and 90Y-DOTATOC in Patients with Carcinoid Tumors

Published in 2011 Listed under Clinical, Poster

David Bushnell, Mark Madsen, Tom O'Dorisio, Yusuf Menda, Beth Schmitt, Thorvardur Halfdanarson, Sue O'Dorisio

  pdf Download Poster (417 KB)

C06 – Description of Initial Treatment for Newly Diagnosed Metastatic Carcinoid (cNET) and Pancreatic Neuroendocrine (pNET) Patients

Published in 2012 Listed under Clinical, Poster

Sarah Bobiack, PhD; Michael A. Choti, MD; Al B. Benson, III MD; Jonathan R. Strosberg, MD; P. Mark Bloomston, MD; Emily K. Bergsland, MD; Carrie C. Zornosa, MSPH; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD; James C. Yao, MD

  pdf Download Poster (862 KB)

C06 – Incidental Diagnosis of Pancreatic Neuroendocrine tumors

Published in 2010 Listed under Clinical, Poster

Asima Cheema MD, Jill Weber MPH, Larry Kvols MD, Jonathan Strosberg, MD

  pdf Download Poster (60 KB)

C06 – One year Follow-up for the Phase I MTD study of Ultratrace Iobenguane I 131 in Patients with Malignant Pheochromocytoma/Paraganglioma (Pheo)

Published in 2009 Listed under Clinical, Poster

R. Edward Coleman, Stanley J. Goldsmith, Richard B. Noto, Kimberly R. Pearson, Katherine A. Kacena, John A. Barrett, Norman D. LaFrance, John W. Babich Corresponding author

  pdf Download Poster (739 KB)

C06 – Impact of Progression on Resource Utilization in the Treatment of Advanced Neuroendocrine Tumor

Published in 2011 Listed under Clinical, Poster

R. Casciano, X. Wang, Z. Liu, R. Parikh, J. Strosberg, R. Riechelmann

  pdf Download Poster (324 KB)

C07 – Ki-67 Proliferative Index and the Tumor Grade Predict Progression Free Survival in Ileal Carcinoids

Published in 2010 Listed under Clinical, Poster

Deepti Dhall ,Rugvedita Parakh, Richard Mertens, Girish Dhall, Catherine Bresee, Delma Ines, Fai Chung, Marissa Li, Steven D Colquhoun, Nicholas N Nissen, Run Yu, HanlinWang and Edward Wolin

  pdf Download Poster (6.97 MB)

C07 – Resection of Liver Metastasis in Midgut Neuroendocrine Tumors Affects 10-Year Survival

Published in 2012 Listed under Clinical, Poster

J. Philip Boudreaux MD; Anne E. Diebold BS; Yi-Zarn Wang MD; Eugene A. Woltering MD

  pdf Download Poster (211 KB)

C07 – Updated Results of a Phase I Study of Pasireotide (SOM230) in Combination with Everolimus in Patients (pts) with Advanced Neuroendocrine Tumors (NET)

Published in 2011 Listed under Clinical, Poster

Jennifer A. Chan, MD, MPH; David P. Ryan, MD; Charles S. Fuchs, MD, MPH; Andrew X. Zhu, MD, PhD; Thomas A. Abrams, MD, Brian M. Wolpin, MD, MPH; Paige Malinowski, BA; Eileen Regan, RN, BSN, OCN; Matthew H. Kulke, MD, MMSc

  pdf Download Poster (145 KB)

C08 – Evaluation of progression-free survival by blinded independent central review in patients with progressive, well-differentiated pancreatic neuroendocrine tumors treated with sunitinib or placebo

Published in 2010 Listed under Clinical, Poster

Pascal Hammel, Daniel Castellano, Eric Van Cutsem, Patricia Niccoli, Sandrine Faivre, Shem Patyna, Deno Klademenos, Dongrui Ray Lu, Richard Chao, Eric Raymond

  pdf Download Poster (385 KB)

C08 – Gender Related Issues in Gluteal Intramuscular Injections

Published in 2009 Listed under Clinical, Poster

Jeana L. Garris, Linda L. DeFord, Cecile G. Dagohoy, Colleen C. Leary, Valentine G. Boving, James P. Brook, Jeannette E. Mares, April E. Boyd, Alexandria T. Phan, James C. Yao

  pdf Download Poster (428 KB)

C08 – Lymph Node Positivity in Patients with Small T1 and T2 Midgut Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

J. Philip Boudreaux MD; Yi-Zarn Wang MD; Anne E. Diebold BS; Eugene A. Woltering MD

  pdf Download Poster (190 KB)

C09 – Phase I/II Study of Everolimus (RAD001) in Combination with Temozolomide (TMZ) in Patients with Advanced Pancreatic Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Matthew H. Kulke, MD, MMSc,; Lawrence Blaszkowsky, MD; Andrew X. Zhu, MD, PhD; Sarah Florio, BS; Eileen Regan, RN, BSN, OCN; David P. Ryan, MD; Jennifer A. Chan, MD, MPH

  pdf Download Poster (110 KB)

C09 – Preliminary Experience with Intra-arterial I-131 MIBG Hepatic Infusion for Progressive Metastatic Low Grade Neuroendocrine Tumors: An Ongoing Work-In-Progress

Published in 2012 Listed under Clinical, Poster

Richard J Campeau, MD, FACNM; Adam M Dowling, MD, FACR; Eugene A Woltering MD, FACS; J Philip Boudreaux, MD, FACS; Yi-Zarn Wang, MD, FACS; Maria M Chester, RN, BSN

  pdf Download Poster (414 KB)

C09 – Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study

Published in 2009 Listed under Clinical, Poster

Thorvardur R. Halfdanarson, William R. Bamlet, Timothy J. Hobday, Robert R. McWilliams, Gloria M. Petersen.

  pdf Download Poster (39 KB)

C09 – Comparison of Clinicopathologic Factors in 122 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution

Published in 2011 Listed under Clinical, Poster

Fadi S. Dahdaleh, MD, Daniel Calva-Cerqueira, MD, Jennifer C. Carr, MD, Junlin Liao, PhD, James J. Mezhir, MD, Thomas M. O'Dorisio, MD, and James R. Howe, MD

  pdf Download Poster (1.08 MB)

C1 - Long-Term Follow Up of Patients with Carcinoid Syndrome Diarrhea Treated with Telotristat Ethyl: A Pooled Analysis of Phase 2 and 3 Trials

Published in 2018 Listed under Clinical, Poster

Abstract ID: 37

Lowell Anthony, Matthew Kulke, Martyn Caplin, Emily Bergsland, Kjell Öberg, Marianne Pavel, Dieter Hörsch, Thomas O’Dorisio, Joseph Dillon,  Pablo Lapuerta, Kenneth Kassler-Taub, Wenjun Jiang

  pdf Download Poster (1016 KB)

C1 - The TELEPATH Phase 3 Study: An Analysis of Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms

Published in 2019 Listed under Clinical

Dieter Horsch; Lowell Anthony; David Gross; Juan Valle; Staffan Welin; Marta Benavent; Kenneth Kassler-Taub; Polina Binder; Phillip Banks; Pablo Lapuerta; Matthew Kulke

Abstract ID: 33

C10 - CLARINET FORTE Baseline Characteristics: Lanreotide Autogel 120 Mg (LAN) Every 14 Days in Patients with Progressive Pancreatic or Midgut Neuroendocrine Tumors During a Standard First-Line LAN Regimen

Published in 2019 Listed under Clinical

Philippe Ruszniewski; Jarosław Ćwikła; Catherine Lombard-Bohas; Ivan Borbath; Tahir Shah; Ulrich-Frank Pape; Xuan-Mai Truong Thanh; Aude Houchard; Marianne Pavel

Abstract ID: 121

C10 - Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients with Neuroendocrine Tumors

Published in 2018 Listed under Clinical, Poster

 Abstract ID: 20

Jordan Gabrielson,  Gianna Girone, Bonita Bennett, Anna Jung

pdf Download Poster (246 KB)

C10 – Prevalence of Functional Tumors in Neuroendocrine Carcinoma: An Analysis from the NCCN NET Database.

Published in 2012 Listed under Clinical, Poster

Michael A. Choti, MD; Sarah Bobiak, PhD; Jonathan R. Strosberg, MD; Al B. Benson, III, MD; P. Mark Bloomston, MD; James C. Yao, MD; Carrie C. Zornosa, MSPH; Emily K. Bergsland, MD; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD

  pdf Download Poster (633 KB)

C10 – The Efficacy and Safety of Pasireotide (SOM230) in the Treatment of Patients with Metastatic Neuroendocrine Tumors (NET) Refractory or Resistant to Octreotide LAR

Published in 2010 Listed under Clinical, Poster

Larry Kvols, Bertram Wiedenmann, Kjell Öberg, Pharis Mohideen, Thomas M. O’Dorisio, Wouter W. de Herder, Gareth Hughes, Rudolf Arnold, Lowell Anthony

  pdf Download Poster (208 KB)

C10 – Neurokinin A Levels Predict Survival in Patients with Well Differentiated Small Bowel Neuroendocrine Tumors

Published in 2011 Listed under Clinical, Poster

Anne E. Diebold BS, J. Philip Boudreaux MD, Yi-Zarn Wang DDS, MD, Lowell B. Anthony MD, Ann Porter Uhlhorn RN, Pamela Ryan BSN, RN, Eugene A. Woltering MD

  pdf Download Poster (265 KB)

C11 - Improvement of Carcinoid Syndrome (CS) Symptoms and Quality of Life (QoL) in CS Patients Treated with Somatostatin Analogs (SSAs)

Published in 2018 Listed under Clinical, Poster

 Abstract ID: 26

Daniel M Halperin, Lynn Huynh, Jennifer L. Beaumont,  Beilei Cai, Rachel Bhak, Sahil Narkhede, Mei S. Duh,  Maureen P. Neary, David Cella

pdf Download Poster (304 KB)

C11 - Somatostatin Analog Use in Patients with Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)

Published in 2019 Listed under Clinical

Taymeyah Al-Toubah; Mintallah Haider; Jonathan Strosberg

Abstract ID: 126

C11 – A Prospective Trial on the Effect of Body Mass Index and Gender on Plasma Octreotide Levels in Patients Undergoing Long Term Therapy With Octreotide LAR

Published in 2009 Listed under Clinical, Poster

Saju Joseph, MD, Gang Li, PhD, Erika Lindholm, MD, Ying Zhou, MS, Vay Liang W. Go, MD, Aaron I. Vinik, MD, PhD, Thomas M. O’Dorisio, MD, Gregg Mamikunian, MS and Eugene A. Woltering, MD, FACS

pdf Download Poster (120 KB)